Management of Gingival Smile using Botulinum Toxi

Not Applicable

• Conditions: Jaw Abnormalities; Gingiva; C05.500.460; A14.549.167.646.480

• Registration Number: RBR-8p9fmn
• Lead Sponsor: Faculdade de Odontologia da Universidade Federal do Rio Grande do Sul

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-03-11
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Data analysis completed
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Patients aged between 18 and 40 years, who presented gingival exposure when smiling, greater than or equal to 3 mm, bilaterally.

Exclusion Criteria

patients with systemic impairment, a history of hypersensitivity to the toxin, immunodeficiencies or who had applied the toxin less than six months ago; patients who received treatment with aminoglycosides, anticholinergic drugs or other agents that could interfere with neuromuscular transmissions or muscle relaxants (as the effect of botulinum toxin can be enhanced); patients with neuropathic diseases of the peripheral system, sclerosis or any disorders of the neuromuscular junction due to the increased risk of clinically significant adverse reactions; patients with infection at the application site, psychologically unstable or pregnant women.

Study & Design

• Study Type: Intervention
• Study Design: Not specified